# Jim McKelvey, Angel Investor

Investor in New York, New York

## About Jim McKelvey, Angel Investor

Jim McKelvey is a serial entrepreneur, investor, and philanthropist best known as the Co‑Founder of Square, where he helped transform digital payments for small businesses worldwide. He has since launched ventures, including Invisibly, focused on data and privacy, and LaunchCode, a nonprofit that trains and places programmers for free. Most recently, he founded Passcom, building the next generation of small business solutions.

Across his career, Jim has combined product innovation with a commitment to expanding access—whether through financial technology, workforce development, or data empowerment. His leadership reflects a consistent focus on solving systemic challenges with scalable, practical solutions.

As an angel investor, Jim has backed about ten companies, with recent investments including Noble Mobile, Rezilient Health, Solis Agrosciences, UNest, and Cazoo. His portfolio spans health, fintech, agtech, and consumer services, reflecting his broad interest in ventures that drive meaningful impact.

## People

- **Jim McKelvey**, Angel Investor

## Key Facts

- **Location:** New York, New York
- **Investor Type:** Angel Investor

## Investment Industries

- Agriculture
- Financial
- Medical/Healthcare
- Technology/Web/App
- Other

## How to Contact

Direct messaging, this investor's website, and their X profile are available with a paid Ask For Funding plan.

- [See plans and pricing](https://askforfunding.com/pricing)
- Already on a paid plan? [Log in](https://askforfunding.com/users/sign_in)

## More on Ask For Funding

- Full profile: https://askforfunding.com/investor/jim-mckelvey-angel-investor
- More investors: [Agriculture Investors in New York](https://askforfunding.com/site/angel-investors/new-york/agriculture)
- Find more investors: https://askforfunding.com/search/investors

Ask For Funding (AskForFunding.com) connects entrepreneurs with angel investors, private investors and venture capital firms in the United States, Canada and Australia.
